What the Peer-Reviewed Record Establishes
The primary research record in Uterine Artery Doppler Velocimetry & Maternal Arterial Stiffness is stratified by study design so that meta-analyses and replicated randomised controlled trials (T1–T2) carry greater epistemic weight than observational cohorts (T3–T4) or preclinical laboratory work (T5). Leading graded findings establish the core empirical baseline: [T3] Our data suggest that vascular assessment in women during pregnancy not only may provide information about maternal vascular health but also can be used to provide information about individual risk factors for placental insufficiency. [4] [T3] The goal of this observational study is to understand how the loss of ovarian function after oophorectomy affects the health and well being of women aged 35-50. [3]
Further clinical and mechanistic stratification across the literature demonstrates: [T3] 1 People's Hospital from September 2022 to December 2024, including 82 patients with GDM and 95 healthy controls. [1] [T3] The menopause transition is associated with a decrease in artery health and an increased risk for weight gain in storing fat in the stomach area which may increase the risk for heart disease. [6]
Comparative Evaluation of Levers & Theoretical Models
Within Reproductive Medicine & Human Fertility → Advanced Maternal Age & Pregnancy After 40, mechanistic and clinical evaluation in Uterine Artery Doppler Velocimetry & Maternal Arterial Stiffness focuses on first- and second-trimester pulsatility index, diastolic notching, pulse wave velocity, and central hemodynamic monitoring. Primary publications in the current corpus span Quantitative imaging in medicine and surgery, American journal of obstetrics and gynecology, University of Jyvaskyla, University of Sao Paulo.
Evolution of the Field, Open Debates & Active Trials
Chronologically, the field evolved through key inflection points: in 2010, Oral L-Citrulline and ADMA in Pregnancy (The purpose of this study is to determine if oral of L-citrulline (3 grams/day) for 3 weeks provided in mid-pregnancy to obese subjects will decrease the plasma ADMA/L-arginine ratio, lower maternal blood pressure, improve endothelial-dependent vascular functi); in 2025, Maternal vascular-placental axis in the third trimester in women with gestational diabetes mellitus, hyperte… (Our data suggest that vascular assessment in women during pregnancy not only may provide information about maternal vascular health but also can be used to provide information about individual risk factors for placental insufficiency); in 2026, Hormonal Regulation of Cardiometabolic Health Study (The goal of this observational study is to understand how the loss of ovarian function after oophorectomy affects the health and well being of women aged 35-50).
Open Questions & Priorities for the Next Research Sweep
Methodological priorities and open empirical questions queued for the next research sweep across Uterine Artery Doppler Velocimetry & Maternal Arterial Stiffness focus on resolving subgroup effect sizes, causal mechanisms, and long-term outcomes:
- Large-scale multicentre randomised controlled trials with standardised live-birth and long-term offspring follow-up in Uterine Artery Doppler and Vascular Stiffness Assessment.
- Age- and subgroup-stratified biomarker validation across diverse human populations.